Living with ankylosing spondylitis (AS) or axial spondyloarthritis (axSpA) can be a journey of navigating chronic joint pain and stiffness. For many, these conditions are diagnosed in the teens or twenties, but many people do not receive a diagnosis until they are much older. Understanding how the disease behaves differently in older patients is important for doctors and patients alike as they look for ways to manage symptoms and plan for the future.
Researchers looked at data from over 6,600 patients with these conditions to see if there were differences between those who developed the disease early in life and those who developed it later. They specifically defined late-onset cases as those diagnosed at age 45 or older. By comparing these two groups, the researchers aimed to see if certain markers, like specific genes or physical signs, changed based on the age of diagnosis.
One of the most consistent findings was related to a specific gene called HLA-B27. This gene is often linked to certain types of inflammatory joint diseases. The study found that people with a late-onset diagnosis were significantly less likely to have this specific gene compared to those diagnosed younger. While this is a clear difference, the researchers noted that this finding cannot be used to diagnose a patient or prove a direct cause for the disease. Other factors, such as whether the patient was male or the amount of visible joint damage on X-rays, did not show a clear difference between the two groups.
It is important to keep these findings in perspective. The study had some limitations, including a wide range of data and a low level of certainty regarding the exact percentage of late-onset cases in the total population. Because the data came from many different sources, it can be hard to pinpoint exact patterns with total certainty.
For patients right now, this research does not change immediate treatment plans. It does, however, provide a clearer picture of how the disease can present differently depending on age. While the lower rate of the HLA-B27 gene in older patients is a notable finding, it is just one piece of a complex puzzle. Doctors will continue to use a variety of factors to treat and manage the condition for everyone, regardless of when their symptoms first began.
